SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 85 filers reported holding SAVARA INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,766,003 | -7.4% | 1,789,948 | -21.7% | 0.02% | 0.0% |
| Q2 2023 | $7,305,058 | +32.4% | 2,286,403 | -19.2% | 0.02% | +26.3% |
| Q1 2023 | $5,517,194 | +4.4% | 2,829,330 | -17.0% | 0.02% | 0.0% |
| Q4 2022 | $5,282,225 | -50.3% | 3,407,887 | -50.3% | 0.02% | -9.5% |
| Q3 2022 | $10,621,633 | +2.4% | 6,852,430 | +0.4% | 0.02% | +10.5% |
| Q2 2022 | $10,370,448 | +13.8% | 6,822,958 | -1.9% | 0.02% | +46.2% |
| Q1 2022 | $9,111,960 | +111.3% | 6,955,664 | +100.0% | 0.01% | +18.2% |
| Q4 2021 | $4,312,000 | +1.9% | 3,477,795 | +13.5% | 0.01% | -8.3% |
| Q3 2021 | $4,230,000 | -57.9% | 3,065,304 | -48.1% | 0.01% | -14.3% |
| Q2 2021 | $10,038,000 | +51.9% | 5,904,460 | +85.9% | 0.01% | -30.0% |
| Q1 2021 | $6,607,000 | +203.1% | 3,176,422 | +67.6% | 0.02% | +185.7% |
| Q4 2020 | $2,180,000 | +42.4% | 1,895,554 | +35.0% | 0.01% | +16.7% |
| Q3 2020 | $1,531,000 | -78.2% | 1,404,519 | -50.3% | 0.01% | -57.1% |
| Q2 2020 | $7,032,000 | +23.7% | 2,824,474 | +5.3% | 0.01% | 0.0% |
| Q1 2020 | $5,686,000 | – | 2,681,992 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,128,593 | $5,898,000 | 0.37% |
| FARALLON CAPITAL MANAGEMENT LLC | 4,452,086 | $5,120,000 | 0.03% |
| Woodline Partners LP | 374,904 | $431,000 | 0.01% |
| Gyon Technologies Capital Management, LP | 19,679 | $23,000 | 0.01% |
| AXA S.A. | 1,895,554 | $2,180,000 | 0.01% |
| WEXFORD CAPITAL LP | 31,253 | $36,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 192,100 | $221,000 | 0.01% |
| Capital Advantage, Inc. | 14,658 | $18,000 | 0.01% |
| RGT Wealth Advisors, LLC | 10,000 | $12,000 | 0.00% |
| Crewe Advisors LLC | 3,910 | $4,000 | 0.00% |